CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websitegenticel.com
CategoryBioTech
Employees
DescriptionCervical Cancer BioPharma Company

Offices

Headquarters
Pasteur-Biotop
25-28 rue du Docteur Roux
Paris , 75724, FRA

Funding

TOTAL $17.7M
VENTURE FUNDING TOTAL $17.7M
Series C, 4/10
IDInvest Partners
Amundi Private Equity Funds
InnoBio Fund
Edmond de Rothschild Venture Capital
$17.7M

Tags

cervical-cancer

Genticel

Gentiel is a clinical-stage biopharmaceutical company focused on therapeutic vaccines for the prevention of cervical cancer in HPV infected women.

Milestones

  • Dollar
    Genticel received $17.7M in Series C funding. (4/5/10)
    Posted 4/5/10 at 10:44pm via onbiovc.com

Videos

Screenshots

Sources

  1. Genticel, S.A.: Series C $17.7M (onbiovc.com) [edit]
Edit This Page
Last Edited 4/5/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy